These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3414608)

  • 1. New guidelines and recommendations on the detection, evaluation, and treatment of patients with undesirable cholesterol levels.
    Naito HK
    Am J Clin Pathol; 1988 Sep; 90(3):358-61. PubMed ID: 3414608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for treatment of high blood cholesterol. The National Cholesterol Education Program Adult Treatment Panel.
    Ernst ND; LaRosa JC
    Bol Asoc Med P R; 1988 Jul; 80(7):258-61. PubMed ID: 3166669
    [No Abstract]   [Full Text] [Related]  

  • 3. National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents.
    Pediatrics; 1992 Mar; 89(3):495-501. PubMed ID: 1741227
    [No Abstract]   [Full Text] [Related]  

  • 4. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
    Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
    J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The National Cholesterol Education Program: guidelines, status, and issues.
    Goodman DS
    Am J Med; 1991 Feb; 90(2A):32S-35S. PubMed ID: 1994713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cholesterol challenge: from laboratory to clinician.
    Naito HK
    Clin Chem; 1988 Feb; 34(2):444-9. PubMed ID: 3342535
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic lifestyle changes and drug treatment for high blood cholesterol in China and application of the Adult Treatment Panel III guidelines.
    Muntner P; Gu D; Reynolds RF; Wu X; Chen J; Whelton PK; He J
    Am J Cardiol; 2005 Nov; 96(9):1260-5. PubMed ID: 16253594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New recommendations for the diagnosis and treatment of plasma lipid abnormalities.
    Schaefer EJ
    Nutr Rev; 1993 Aug; 51(8):246-53. PubMed ID: 8302497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.
    Arch Intern Med; 1988 Jan; 148(1):36-69. PubMed ID: 3422148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of high blood cholesterol levels among adults in the United States.
    Sempos C; Fulwood R; Haines C; Carroll M; Anda R; Williamson DF; Remington P; Cleeman J
    JAMA; 1989 Jul; 262(1):45-52. PubMed ID: 2733124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection, evaluation, and treatment of high blood cholesterol in adults].
    Rev Panam Salud Publica; 2001 May; 9(5):338-44. PubMed ID: 11476023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol: precursor to many lipid disorders.
    Jones PH
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical appraisal of revised cholesterol guidelines for the very high-risk patient.
    Rosenson R; Lloyd-Jones D;
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
    JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III.
    Talbert RL
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemia.
    Persell SD; Lloyd-Jones DM; Baker DW
    J Gen Intern Med; 2006 Feb; 21(2):171-6. PubMed ID: 16390501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on lipid-lowering therapy and LDL-cholesterol targets.
    Wiviott SD; Cannon CP
    Nat Clin Pract Cardiovasc Med; 2006 Aug; 3(8):424-36. PubMed ID: 16874355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines.
    Goldman L; Coxson P; Hunink MG; Goldman PA; Tosteson AN; Mittleman M; Williams L; Weinstein MC
    J Am Coll Cardiol; 1999 Sep; 34(3):768-76. PubMed ID: 10483959
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.